London, England, United Kingdom · Hybrid
Location: London (Hybrid) The Mission: Why We Exist Genomics is a science-led transatlantic TechBio combining large-scale genetic and health data with proprietary analytics to accelerate drug discovery and advance predic…
Skills: Pricing Models, Resource Utilisation Tracking, Budgeting, Forecasting, Variance Analysis
London, England, United Kingdom · Hybrid
Location: London (4 days a week in office) The Mission: Why We Exist Genomics is a science-led transatlantic TechBio combining large-scale genetic and health data with proprietary analytics to accelerate drug discovery a…
Skills: Diary Management, Event Coordination, Travel Coordination, Expense Management, Professional Communication
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
The FP&A Analyst manages pricing models for sales proposals and tracks resource utilisation to ensure project profitability. They are responsible for reconciling timesheets, supporting month-end accruals, and translating financial data into commercial narratives for customers.
Candidates should be part-qualified accountants (CIMA, ACCA, ACA) or hold a relevant degree with experience in commercial finance within a professional services environment. Proficiency in advanced Excel or Google Sheets and strong analytical skills are required.
Location: London (Hybrid)
Genomics is a science-led transatlantic TechBio combining large-scale genetic and health data with proprietary analytics to accelerate drug discovery and advance predictive, preventative healthcare. We are united by a single vision to help people live longer, healthier lives, using the power of genomics.
Genomics aims to help people live longer, healthier lives in two ways: super-charging drug discovery and development for novel treatments with our AI-enabled advanced genetic analytics platform, and by helping people understand their personal risk of common chronic diseases through polygenic risk scores - giving doctors and health systems the chance to get the right people into the right prevention, screening and treatment programmes at the right time.
Sitting at the intersection of finance, commercial operations and project delivery, our FP&A Analyst keeps the engine of our project-based services business turning. It is an excellent next step for a commercially minded, part-qualified finance professional with project consultancy experience who wants to deepen their business partnering exposure inside a purpose-driven healthcare and life sciences company.
You will build and refine pricing models that shape live sales proposals, then pull complex data from across the business into a single, reliable version of the truth. You will own resource utilisation tracking — making sure projects are properly staffed and profitable — reconcile timesheets, support WIP and month-end accruals, and step into customer-facing conversations to translate the numbers into commercial narratives.
Part-qualified accountant (CIMA, ACCA, ACA or equivalent) actively studying — a relevant BSc or MSc also considered
Commercial finance, FP&A or analyst experience within a project consultancy or professional services environment
Strong analytical and problem-solving skills, with the ability to turn complex data into clear, actionable insight
Hands-on with timesheet collation, utilisation reporting or project cost tracking
Confident across budgeting, forecasting and variance analysis
Advanced Excel and/or Google Sheets — modelling, pivot tables and data manipulation
An excellent communicator who builds effective relationships at every level
We are committed to providing a transparent, supportive, and rewarding work environment.
Competitive Reward: Salaries are externally benchmarked annually to ensure market-aligned compensation.
Clear Career Path: A straightforward, open progression framework means you'll always know the path to promotion and how to achieve your next career goal.
Continuous Learning: Including external courses and a wide library of L&D materials, because your growth is our success.
Holiday: 25 days annual leave, plus bank holidays, plus an extra 3-day company-wide shutdown at year-end.
Financial & Health Security: Robust benefits including a market-leading pension scheme, comprehensive private health insurance for you and your family with NO excess, critical illness, and life assurance.
Enhanced Leave: Enhanced paid family leave to support all new parents.
Hybrid Working
Truly Inclusive Time Off: Our 'Bank Your Bank Holiday' program allows you to exchange public holidays for dates that hold personal or cultural significance to you.
Vibrant Social Culture: From regular Town Halls and team picnics to organised sports events, our social committee ensures frequent opportunities to connect and celebrate.
Green Commute: Cycle-to-Work scheme and convenient office locations near major transport hubs.
If this opportunity excites you, apply now!
We are dedicated to creating a diverse environment and are proud to be an equal-opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.
Genomics politely requests no contact from recruitment agencies. We do not accept speculative CVs from recruitment agencies nor accept the fees associated with them
Transforming health, healthcare and drug discovery and development through the power of genomics
We are a pioneering transatlantic TechBio company that aims to transform health through the power of genomics. The company was formed in 2014 by four world-leading statistical and human geneticists at the University of Oxford, including Professor Sir Peter Donnelly and Professor Gil McVean. We use large-scale genetic information to realise preventative medicine and improve drug discovery. We're a world-leader in genomic prevention: a paradigm-changing approach to sustainable healthcare which for the first time allows reliable, personalised estimates of risk for all the common diseases and cancers, well ahead of disease manifestation, allowing accurate and early interventions and tailored screening. Our proprietary algorithms and databases offer something no competitor can: the ability to accurately link minute variation across the entire genome to changes in thousands of biological measurements and disease outcomes, to generate population-level insights for healthcare systems, individual-level insights for clinicians about the risk of common diseases, and new understanding of disease processes. We work with leading life sciences and biotech companies, including Novo Nordisk and Vertex. Our team is a multi-disciplinary group of world experts focused on finding powerful and creative solutions for bringing subject-leading science to as wide an audience as possible, and, in doing so, offer the chance of transforming lives around the world. The workforce is highly qualified and consists of over 150 people, including world-leading genomic scientists, computational biologists, statisticians, software engineers, product developers, data scientists and commercial strategists. We are headquartered in Oxford, with offices in Cambridge (UK), London (UK), and North Carolina (US), with labs in Massachusetts (US).
Offices: King Charles House, Park End Street, Oxford, Oxfordshire OX1 1JD, GB · 50-60 Station Road, Cambridge, England CB1 2JH, GB · SPACES, 555 S Mangum St Suite 100, Durham, North Carolina 27701, US · King's Cross Road, London, England, GB
Transforming health, healthcare and drug discovery and development through the power of genomics
We are a pioneering transatlantic TechBio company that aims to transform health through the power of genomics. The company was formed in 2014 by four world-leading statistical and human geneticists at the University of Oxford, including Professor Sir Peter Donnelly and Professor Gil McVean. We use large-scale genetic information to realise preventative medicine and improve drug discovery. We're a world-leader in genomic prevention: a paradigm-changing approach to sustainable healthcare which for the first time allows reliable, personalised estimates of risk for all the common diseases and cancers, well ahead of disease manifestation, allowing accurate and early interventions and tailored screening. Our proprietary algorithms and databases offer something no competitor can: the ability to accurately link minute variation across the entire genome to changes in thousands of biological measurements and disease outcomes, to generate population-level insights for healthcare systems, individual-level insights for clinicians about the risk of common diseases, and new understanding of disease processes. We work with leading life sciences and biotech companies, including Novo Nordisk and Vertex. Our team is a multi-disciplinary group of world experts focused on finding powerful and creative solutions for bringing subject-leading science to as wide an audience as possible, and, in doing so, offer the chance of transforming lives around the world. The workforce is highly qualified and consists of over 150 people, including world-leading genomic scientists, computational biologists, statisticians, software engineers, product developers, data scientists and commercial strategists. We are headquartered in Oxford, with offices in Cambridge (UK), London (UK), and North Carolina (US), with labs in Massachusetts (US).
Offices: King Charles House, Park End Street, Oxford, Oxfordshire OX1 1JD, GB · 50-60 Station Road, Cambridge, England CB1 2JH, GB · SPACES, 555 S Mangum St Suite 100, Durham, North Carolina 27701, US · King's Cross Road, London, England, GB
